If you're passionate about immunotherapy innovation and driven to shape the future of next-generation T-cell therapies, we invite you to be part of our journey. Explore exciting career opportunities and join our dynamic team at Alfa Cytology, where we’re advancing the ETESTM Platform to transform preclinical cancer research and unlock safer, smarter immunotherapy solutions.
Searching for Opportunities
Alfa Cytology is a pioneering biotechnology company dedicated to advancing the ETESTM platform (Endogenous T-cell Engagement System) for preclinical immunotherapy development. Our expert team of immunologists, molecular engineers, and oncology researchers is committed to delivering next-generation T-cell solutions that address the complexity of cancer treatment. Through innovative modular design and rigorous preclinical validation, we empower your research and accelerate the journey toward safer, more effective cellular therapies.
The ETESTM Platform is a modular T-cell activation system developed for next-gen immunotherapy. Alfa Cytology offers full preclinical development services to support your pipeline.
Copyright © 2025 Alfa Cytology. All rights reserved.
